|
 The prosecutors' office said the investigation had been opened to
determine whether there was a criminal element in any mistakes made
or whether it was simply the result of clinical risks involved.
France's Health Ministry said last month that Portuguese drugmaker
Bial and French laboratory Biotrial were at fault "on several
counts" for the drug trial.
Participants in the phase I trial were given the experimental drug
made by Bial at a private facility in the city of Rennes run by
France's Biotrial.
All trials of the drug, designed to treat mood and anxiety issues as
well as coordination disorders linked to neurological issues, have
been suspended.
(Reporting by Leigh Thomas; Editing by Hugh Lawson)
[© 2016 Thomson Reuters. All rights
reserved.] Copyright 2016 Reuters. All rights reserved. This material may not be published,
broadcast, rewritten or redistributed. |
